Cargando…

A commentary on the “Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis”

Detalles Bibliográficos
Autor principal:	Akhavi Milani, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866136/ https://www.ncbi.nlm.nih.gov/pubmed/35242889 http://dx.doi.org/10.1016/j.ejro.2022.100408

Ejemplares similares

Response to: A commentary on “Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis”
por: Ortiz, Andrés Felipe Herrera, et al.
Publicado: (2022)

Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis
por: Ortiz, Andrés Felipe Herrera, et al.
Publicado: (2022)

Osteoid osteoma of the second metatarsal bone diagnosed on MRI: A case report and literature review
por: Daghighi, Mohammad Hossein, et al.
Publicado: (2021)

CT Radiomics in Predicting EGFR Mutation in Non-small Cell Lung Cancer: A Single Institutional Study
por: Wu, Shanshan, et al.
Publicado: (2020)

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2021)

Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer
por: Felfli, Mehdi, et al.
Publicado: (2023)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
por: Zhang, Guojin, et al.
Publicado: (2020)

Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2021)

Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis
por: Lv, Li, et al.
Publicado: (2020)

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Yue-Lun, et al.
Publicado: (2016)

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
por: Buder, Anna, et al.
Publicado: (2020)

The predictive value of (18)F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population
por: Wang, Jian, et al.
Publicado: (2022)

Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer
por: Yamazaki, Motohiko, et al.
Publicado: (2022)

The geometric features of tibiofemoral joint associated with anterior cruciate ligament injury: Reliability of measurements on conventional MRI
por: Akhavi Milani, Ali, et al.
Publicado: (2022)

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
por: Phan, Thang Thanh, et al.
Publicado: (2019)

Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative (18)F FDG-PET/CT metrics
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

EGFR ‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
por: Phan, Thang Thanh, et al.
Publicado: (2021)

A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
por: Cui, Ran, et al.
Publicado: (2022)

Can (18)F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis
por: Du, Bulin, et al.
Publicado: (2021)

The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon EGFR Mutations—The Mutation Patterns, Use of Different Generations of EGFR-TKIs, and Concurrent Genetic Alterations
por: Tan, Jiarong, et al.
Publicado: (2021)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
por: Fang, Shu, et al.
Publicado: (2014)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis
por: Yao, Guangyu, et al.
Publicado: (2020)

EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
por: Chen, Quan, et al.
Publicado: (2022)

Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
por: Buonerba, Carlo, et al.
Publicado: (2019)

Predicting EGFR Mutation in Lung Adenocarcinoma: Development and Validation of the EGFR Mutation Predictive Score (EMPS) in Bali, Indonesia
por: Njoto, Edwin Nugroho, et al.
Publicado: (2023)

Prevalence and Patterns of EGFR Mutations in Non-small Cell Lung Cancer in the Middle East and North Africa
por: Boustany, Youssra, et al.
Publicado: (2022)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
por: Ali, Azhar, et al.
Publicado: (2018)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis
por: Kuan, Feng-Che, et al.
Publicado: (2015)

EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
por: Chen, Chang-Hung, et al.
Publicado: (2022)

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer
por: Janssen, Julie M., et al.
Publicado: (2022)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma
por: Yang, Chunsheng, et al.
Publicado: (2020)

CT-based decision tree model for predicting EGFR mutation status in synchronous multiple primary lung cancers
por: Luo, Yingwei, et al.
Publicado: (2023)

CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer
por: Lian, Weisheng, et al.
Publicado: (2017)

Prediction of EGFR Mutation Status in Non–Small Cell Lung Cancer Based on Ensemble Learning
por: Feng, Youdan, et al.
Publicado: (2022)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Comparation of EGFR-TKI (EGFR tyrosine kinase inhibitors) combination therapy and osimertinib for untreated EGFR-mutated advanced non-small cell lung cancers: A systematic review and network meta-analysis
por: Lei, Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2tolasg9lih3rn49u9c1aabs92